Corrinne Burns

Royal Pharmaceutical Society Correspondent

Corrinne Burns is Royal Pharmaceutical Society Correspondent at The Pharmaceutical Journal.

UK signs up to European rare diseases network

The National Institute for Health and Care Research said membership of the European Rare Diseases Research Alliance will open “new pathways for UK researchers to participate in international clinical trials”.…

New antidepressant prescriptions lower than pre-pandemic levels, study finds

Researchers found that the incident rate of central nervous system medicines was 4.1 per 1,000 person-months in February 2024, which is down from 6.0 per 1,000 person months in February 2020.…

Blood pressure and cholesterol in older adults with obesity found to be similar to people with healthy BMIs

Study authors said their findings coincide with an increased use of cholesterol-lowering medication and blood pressure medication in recent years among adults aged over 40 years with obesity, compared with adults with normal BMIs.…

Community pharmacies receive government obesity care funding

The announcement is part of a UK-wide programme of innovative schemes that could include the provision of weight-loss drugs.…

UKPPLAB to cease operations as it hands over to pharmacy bodies

In a ‘Concordat for delivery’, representatives of seven pharmacy bodies have outlined pre-requisites for the development of “an ambitious and inclusive royal college as a wider home for pharmacy by 2030”.…

Pharmacist and dentist-led smoking cessation clinic led to 20% quit rate

The smoking cessation programme offered continuous behavioural counselling, pharmacological therapy and dental care incentives for participants who expressed a willingness to quit.…

NICE recommends first drug to delay symptoms of type 1 diabetes for NHS use

In what has been described as “an extraordinary moment”, teplizumab has been recommended as an immunotherapy for adults and children aged eight years and older with stage two type 1 diabetes mellitus.…

Minimum age set for puberty blockers trial

To participate in the ‘PATHWAYS’ clinical trial, a modified protocol has ruled that birth-registered females must be aged between 11 and 16 years, and birth-registered males must be aged between 12 and 16 years.…

Pharmacy regulator warns against promotion of prescription weight-loss medicines

A notice has reminded businesses that they cannot advertise prescription-only medicines or prescription-only medical treatments to the public.…

Community pharmacy delivers more than 4.5 million flu vaccines in 2025/2026

NHS Business Services Authority data reveals that during the 2025/2026 flu season, the Midlands region delivered the most vaccinations through community pharmacy in England, with more than 860,000.…